Senseonics HoldingsSENS
About: Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Employees: 117
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
101% more capital invested
Capital invested by funds: $20.8M [Q3] → $41.8M (+$21M) [Q4]
98% more call options, than puts
Call options by funds: $324K | Put options by funds: $164K
47% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 19
2.33% more ownership
Funds ownership: 11.08% [Q3] → 13.41% (+2.33%) [Q4]
8% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 24
5% less funds holding
Funds holding: 129 [Q3] → 123 (-6) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Vernon Bernardino 24% 1-year accuracy 15 / 62 met price target | 226%upside $2 | Buy Reiterated | 5 Mar 2025 |
Financial journalist opinion
Based on 6 articles about SENS published over the past 30 days









